Angle Share Price. AGL - Stock Quote, Charts, Trade History, Share Chat, Financials. Angle Plc

Gold vs US Dollar

Home
Investing
Stocks
UK
LSE
Angle Plc (AGL)
Angle Plc (AGL) Share Price

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Angle Plc	LSE:AGL	London	Ordinary Share	GB0034330679	ORD 10P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	0.00	0.0%	18.00	80,199	08:00:00

Bid Price		Offer Price	High Price	Low Price	Open Price
17.50		18.50	18.00	18.00	18.00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Business Consulting	1.04	-21.69	-	-	42.33

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
16:05:51	O	110	18.144	GBX

Related Shares
Astrazeneca (AZN), Gsk (GSK), Yourgene Health (YGEN), Fusion Antibodies (FAB)

Angle (AGL) Latest News

Angle News

Date	Time	Source	Headline
05/6/2023	12:26	ALNC	IN BRIEF: Angle hires Swansiger as new COO and Miller as new CSO
05/6/2023	07:00	RNSNON	Angle PLC ANGLE announces senior management appointments
25/5/2023	14:34	ALNC	IN BRIEF: Angle customer to use biopsy products in clinical trial
25/5/2023	07:00	UKREG	Angle PLC Pharma services contract with Artios Pharma
22/5/2023	13:53	ALNC	IN BRIEF: Angle promotes Jan Groen to chair, replacing Garth Selvey
22/5/2023	07:00	UKREG	Angle PLC Board change - appointment of new Chairman
21/4/2023	12:04	RNSNON	Angle PLC ANGLE presentation via Investor Meet Company
21/4/2023	10:43	ALNC	Angle loss widens in 2022 despite being "breakthrough" year
21/4/2023	07:00	UKREG	Angle PLC Results for the year ended 31 December 2022
19/4/2023	17:37	ALNC	TRADING UPDATES: Angle partners with BioView; First Class hails nickel

More Angle News

Angle Investors Angle Takeover Rumours

Angle (AGL) Discussions and Chat

Angle Forums and Chat

Date	Time	Title	Posts
05/6/2023	19:37	ANGLE PLC - 2019 THREAD - LIQUID BIOPSY COMPANY	19,480
05/6/2023	12:10	ANGLE PLC IT'S A SPOOF	1,214
02/6/2023	14:13	Still time to look at Angle (AGL)	1,596
20/4/2023	13:00	AGL has been Jinxed by the God of Shite. 10p Target	215
17/1/2023	21:28	ANGLE [12.75p] TARA*S SHARE OF THE DECADE "TARGET PRICE Ј100.00 PER SHARE."	3,743

Add a New Thread

Angle (AGL) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
15:05:52	18.14	110	19.96	O
10:04:35	18.19	10,945	1,990.88	O
09:43:10	17.63	767	135.18	O
09:11:28	18.19	27,422	4,988.03	O
08:09:02	17.77	10,000	1,777.00	O

View all Angle trades in real-time

Angle (AGL) Top Chat Posts

Top Posts
Posted at 04/6/2023 00:31 by bones698 What concerns me is we have a head start on the competition but the slow adoption of CTC and it's commercialisation will allow then to catch up given the length of time it seems to be taking for agl to get a foot hold . Given the size and resources of the competition and our apparent slow progress it does add to the concern that agl are just not urgent enough in their approach and ANs quite laid back attitude because he is financially ok doesn't spark confidence agl will maintain their advantage . It's for reasons like this I suspect agl will end up a niche product whereas then vulkk of the money will go to the vug pharma companies pushing their products even if they are less superior . Many times a lesser product wins the game due to getting the coverage and press dominating the other and by then it's too late . ANs comments and beahvuour over the last 12 months or so does little to make me believe the story will get much better any time soon if at all . Over a decade has gone by . Agl have FDA yet here we are at 18p . Doesn't look like a company on the cusp of greatness infact the last 12 months have been pretty horrific from an investment point of view and whilst there are times be a disconnect between value and progress I think the market is saying they expect agl to struggle . I tend to agree seeing the bods own goals and shareholder destruction self inflicted for the most part . Still hoping for some earth shattering news but can't see much hope of it and where from . Meanwhile funding issues fast approach . For me ANs understanding of the market place has always been lacking massively and this year has shown that in spades imo . Read Full Thread Follow Reply
Posted at 02/6/2023 14:01 by bones698 I think funding issue is what's keeping this firmly where it is and the market knows what's coming . The company itself has said 2026 to break even and I would say that's if things go to plan which they rarely do with agl . The chances of a big uplift from a deal also look unlikely given most deals with be initial trial size . The Solaris one is the one that stands out as a possible smoking gun but that is far from a done deal at this point . It's hard to see what catalyst agl can deliver that would cause the share price to rise significantly from these levels with the funding getting ever closer . For once I hope agl proves me wrong but I am struggling to see where such news will come from at this point. Given the history and way the last year has gone I'm struggling to find positives still . Things are halle jng just not earth shattering news and that's what's needed Read Full Thread Follow Reply
Posted at 25/5/2023 13:54 by bones698 Think a few have pointed out the. Problem is what is going to be the news that will move the shareprice if any . We know they are going to need funds with a year at the latest but nothing is moving the price which means there could be a dillutive fund raise anytime later this year or early next year and this seems to be weighing heavily on the shareprice . Solaris news as one suggested might but it will depend on what the deal is and If there are any numbers to go with it . Even then I think the shareprice might just sit there it it is . It's worrying that we have now signed 3 deals but no effect on the share price . They need a catalyst and while many keep suggesting several possibilities there is nothing like getting the FDA news coming imo . Hope I'm wrong but the reality is they are going to need 20-30 million to get to 2026 approx . Time between deals just let's the share price drift lower too as there seems little interest from buyers. There is a need for a smoking ace up ANs sleeve I just worry there isn't one Read Full Thread Follow Reply
Posted at 12/5/2023 19:10 by paul planet earth Bones698 So I can only assume that you are lying. And never banked a 75% profit on AGL share dealing..Funny you knock Nanoco for no revenues or cash yet they seem to have far more potential than AGL where you are heavily invested and whats more Nanoco have a tiny £100k monthly cash burn rate and $75m of cash coming in from Samsung plus a cash runway fully funded to 2025 unlike AGL which is running out of cash fast, no customers, no revenues, and uncertain future. You posted this on the Nanoco BB regarding AGL. "If you had bought agl when I told you you would have been able to make nearly 75% in a week rather than festering here with sour grapes . Still your doing ever so well here keeping hold while the share price tunmbles" Can you elaborate on actual AGL trade deals placed. dates bought, sold, and amounts, to achieve a 75% return, thanks. Pls note hindsight deals don't constitute actual trade deals placed and profits earned Read Full Thread Follow Reply
Posted at 12/5/2023 13:08 by bones698 kan agree there is lots of possibilities ahead but they need to turn some of those into lucrative contracts and pretty soon otherwise funding becomes an issue . they didn't say what revenues were up to which I thought was poor or the current cash position , not hard to be up on 0.5m revenue tbh and left it open to interpretation like they do quite often. potential is there but its how fast they can realise it and can they get the share price up before more funding is due. The company have said 2026 now before breakeven so it cant be ignored although many lths seem to try to . I expect we will see more contract wins and as the assays become available should accelerate but its a quite short window between that and needing more money and we are currently sat in a rut regarding the share price with very little to act as a catalyst . as for other companies raising hundreds of millions it would be nice to see some of that money coming agls way but thus far not much of it has . for me they are and have taken a gamble on spending the money on assay work now hence the 22m plus of losses but that only works if they can get the price a lot higher ands i don't see anything coming soon enough to do that . we have already seen several deals announced with little to no impact, wether that's due to iis selling or the poor way they were delivered , thats a concern given the timeline for big deals looks some way away still . i ofc hope they find a way to lift the price just struggling to see how in the coming 6 to 9 months given the timelines the company have been telling everyone . Read Full Thread Follow Reply
Posted at 12/5/2023 05:06 by paul planet earth Bones698 You posted this on the Nanoco BB regarding AGL. "If you had bought agl when I told you you would have been able to make nearly 75% in a week rather than festering here with sour grapes . Still your doing ever so well here keeping hold while the share price tunmbles" Can you elaborate on actual AGL trade deals placed. dates bought, sold, and amounts, to achieve a 75% return, thanks. Pls note hindsight deals don't constitute actual trade deals placed and profits earned. Read Full Thread Follow Reply
Posted at 30/4/2023 18:05 by bones698 It was ok but that's about it and that's not really cutting it at this time when the share price is under pressure . Everyone can have their opinion of the presentation but in the end the shareprice fell 3p after it so not exactly a resounding success . I think that tells the real assessment of it far better Plenty of info as there usually is and AN did a good job of trying to explain things so investors could understand but when it comes to deals and profits of the business that's where the company have lacked impetuous and still seem to be facing headwinds . The system works and they are creating a good array of tests and assays etc but it's going to take time and that I think is the concern . Even agl are mentioning funf raises in the presentation and that will keep a lid on the shareprice unless something huge is announced to break the trend and lift the share price significantly . Early 2024 sounds like a lot will be happening so I would guess we won't see any funding until a lot of that news is out and hoping the share price is a lot higher by then . What we get in the meantime doesn't sound like a lot really unless some deals can get done with the 30 plus they are in talks with . Talks do seem to be taking an eternity so hoping some more deals are close . As for being for sale they sounded like it was a good possibility but that will be down to shareholders . True . Another waiting game to see if they can deliver . I think they misjudged how long it would take to break even and hence more money will be needed . Not much on more cost savings just Canada and trying to look after the cash . I suspect losses are still very high with all the development costs and assays etc . All a bit unclear as no guidance in results on cash position and burn rate going forward . Traders will move the shareprice until something else changes the range imo . My assessment of it anyway I'm sure others will see it differently They said expecting break even in 2026 which I would suggest means they will need another 20m approx if revenues ramp up and the losses reduce until then . That's not actually too bad if they can get the shareprice higher before it. It also shows that revenues are increasing rapidly albeit from a very low starting point and if that continues things might work out ok. I hope they are working hard on getting more deals delivered asap as that is what's needed to break the shackles and not taken their foot off the gas now they have done a couple of small deals . Longer term they will possibly become bigger deals Read Full Thread Follow Reply
Posted at 30/4/2023 15:44 by astra1vision AMARETTO states that AGL share price out of sinc to comparable companies. Difference is those companies don’t have AN destroying the share price That’s key. Read Full Thread Follow Reply
Posted at 21/4/2023 09:37 by eastender boy of course there will be another cash raise. assuming early next year. Agl are hoping that some big news or orders are out before then so the share price has recovered from where it is today. The company will survive and grow to be a large player in their field but at what dilution to the longer term holders. imho we are at the bottom of the share price and the short term (8 months) we should at least double to 40-50p assuming above happens. good luck all. its been a very long ride so far for some of us. Read Full Thread Follow Reply
Posted at 20/4/2023 08:18 by bagpuss67 Mr K. You know I respect your opinion and would defer to your better knowledge of AGL. I agree things can change very quickly with AGL and I really hope they do. But honestly what do you see as the catalyst for that in the next 8 months? They are burning £1.7m or so a month. They cannot wait until much into 2024 to raise again. So that catalyst will need to occur in that period. My concern is that the usual game will play out of IIs being sounded out about a raise and just becoming a major headwind to the share price Essentially will the share price reach escape velocity before a raise. Genuinely interested in what you see as value inflexion points over the next 8 months or so. EDIT. And the confidence level you have in them ocurring Read Full Thread Follow Reply

Angle share price data is direct from the London Stock Exchange

Your Recent History

LSE

AGL

Angle

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea

V: D: 20230607 17:07:48